Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset - HMS LINCS Database

Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 1 of 2: Normalized growth rate inhibition values - Dataset (ID:20343)

Filter results: >>>>

Cell	Small Molecule	Small Mol Concentration (uM)	Primary Target	Pathway	Mean Normalized Growth Rate Inhibition Value	Increased Fraction Dead
BT-20	Palbociclib	0.1	CDK4/6	Cell cycle	0.3557	0.03619
BT-20	Palbociclib	0.31623	CDK4/6	Cell cycle	0.2359	0.04751
BT-20	Palbociclib	1.0	CDK4/6	Cell cycle	0.2044	0.04646
BT-20	Palbociclib	3.1623	CDK4/6	Cell cycle	0.1624	0.05010
BT-20	AZD7762	0.001	CHK1/2	Cell cycle	1.1198	-0.00253
BT-20	AZD7762	0.0031623	CHK1/2	Cell cycle	1.2431	-0.00726
BT-20	AZD7762	0.01	CHK1/2	Cell cycle	1.2200	0.00225
BT-20	AZD7762	0.031623	CHK1/2	Cell cycle	1.2229	0.01175
BT-20	AZD7762	0.1	CHK1/2	Cell cycle	1.1714	0.04490
BT-20	AZD7762	0.31623	CHK1/2	Cell cycle	0.9454	0.07692
BT-20	AZD7762	1.0	CHK1/2	Cell cycle	0.5068	0.21188
BT-20	AZD7762	3.1623	CHK1/2	Cell cycle	-0.1525	0.50057
BT-20	AZD7762	10.0	CHK1/2	Cell cycle	-0.5785	0.71162
BT-20	Volasertib	0.0001	PLK	Cell cycle	1.0476	-0.00114
BT-20	Volasertib	0.00031623	PLK	Cell cycle	1.0308	0.00572
BT-20	Volasertib	0.001	PLK	Cell cycle	1.0085	0.00742
BT-20	Volasertib	0.0031623	PLK	Cell cycle	0.8266	0.05236
BT-20	Volasertib	0.01	PLK	Cell cycle	0.0133	0.34529
BT-20	Volasertib	0.031623	PLK	Cell cycle	-0.4356	0.63889
BT-20	Volasertib	0.1	PLK	Cell cycle	-0.5218	0.70449
BT-20	Volasertib	0.31623	PLK	Cell cycle	-0.5339	0.71936
BT-20	Volasertib	1.0	PLK	Cell cycle	-0.4694	0.64260
BT-20	Dinaciclib	0.0001	pan CDK	Cell cycle	0.9253	0.00567
BT-20	Dinaciclib	0.00031623	pan CDK	Cell cycle	1.0258	-0.00375
BT-20	Dinaciclib	0.001	pan CDK	Cell cycle	1.0071	-0.00417